Companies: 10,795·Total market cap: $144.5T
Dyadic International, Inc.

Dyadic International, Inc.

DYAINASDAQHealthcare● Active
$0.70
$-0.01(-1.63%)
Market Cap$25470651
P/E Ratio
52W High$1.35
52W Low$0.65
Overview

Dyadic International, Inc. (DYAI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · DYAI · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.21dyai eps ttm · dyai earnings per shareEarnings history
PE Ratio (TTM)dyai pe ratio ttm · dyai price to earningsPE Ratio deep dive
Revenue (TTM)$3.0Mdyai revenue ttm · dyai annual revenueFull revenue history
Dividend YieldNo Dividenddoes dyai pay dividends · dyai dividend yieldDividend history
Shares Outstanding32.6Mdyai shares outstanding · dyai floatShares outstanding history
Next EarningsAug 12, 2026Est.dyai earnings date · dyai next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$1.2M▼ 64.74% YoY
202320242025
dyadic international, inc. revenue · dyai revenue 2025
FY 2025Net Income-$7.4M▼ 26.78% YoY
202320242025
dyadic international, inc. net income · dyai profit 2025
FY 2025EPS$-0.23▼ 15.00% YoY
202320242025
dyai eps · dyadic international, inc. earnings per share 2025
TTM:Revenue: $3.0MNet Income: -$7.3MEPS: $-0.21View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis dyai a buy · dyai analyst rating
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$3.00Low
$0.70Current
$3.00Avg Target329.18% upside
$3.00High
dyai price target · dyai 12 month forecast

Total: 2 · Buy rate: 50.0%

The DYAI analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +329.18% upside from the current price of $0.70.

Stock Performance

Full History
1D-1.63%
1W+0.43%
1M-8.81%
3M-8.94%
YTD-25.64%
1Y-28.84%
5Y-81.89%

About Dyadic International, Inc.

CEOMark A. Emalfarb
IPO DateJan 16, 2008
Employees6
CountryUS
Websitedyadic.com

Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activitie…

what is dyadic international, inc. · dyai stock overview · dyadic international, inc. company profile · who is dyadic international, inc. ceo · dyai NASDAQ · dyadic international, inc. headquarters · dyadic international, inc. business segments

About Stock Overview & Key Data

Dyadic International, Inc. (DYAI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 16, 2008. As of the latest trading session, DYAI stock price is $0.70, with a market capitalization of $25.5M. The stock has returned -28.84% over the past 12 months and -25.64% year-to-date.

According to 2 Wall Street analysts, the consensus rating for Dyadic International, Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, Dyadic International, Inc. reported revenue of $1.2M and net income of -$7.4M. For detailed data — including Dyadic International, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Dyadic International, Inc. (DYAI) stock price is $0.70. The stock is traded on NASDAQ under the ticker symbol DYAI. The 52-week range is $0.65 – $1.35.

DYAI stock priceDYAI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice